News
Jabil acquires Pharmaceutics International, Inc.
Jabil has acquired of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling,...
U.S. FDA approves Vertex’s JOURNAVX for adults with moderate-to-severe acute pain
The U.S. Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals' JOURNAVX (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the...
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in...
The European Commission has authorised ViiV Healthcare's Vocabria (cabotegravir long-acting injections) in combination with Johnson & Johnson’s Rekambys (rilpivirine long-acting injections) for the treatment of HIV-1 infection in...
